Global Carcinoembryonic Antigen (CEA) Market by Type (CD66a, CD66b, CD66c, CD66d, CD66e, CD66f), By Application (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, Thyroid Cancer, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global carcinoembryonic antigen (CEA) market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, rising awareness about cancer screening, and technological advancements in diagnostic techniques. The global CEA market is segmented on the basis of type into CD66a, CD66b, CD66c, CD66d, CD66e, and CD 66f. The colorectal cancer segment is expected to account for the largest share of the global CEA market in 2018. This can be attributed to factors such as early diagnosis and treatment options for colorectal cancer patients and rising prevalence of colorectal cancer globally. On the basis of application, the global CEA market is divided into ovarian cancer, pancreatic cancer breastcancer thyroidcancerand others segments.



Get Free Sample Report

Product Definition:

Carcinoembryonic antigen (CEA) is a glycoprotein that is produced by many types of tumors, including cancers of the colon, rectum, breast, lung, and pancreas. CEA levels in the blood or other body fluids can be measured to help determine whether a person has cancer or to monitor the progress of cancer treatment.

CD66a:

CD66a is also known as B7-1, it's a member of the family of ligands that bind to CD28 and its related receptors. It was first identified in 1994 as a novel intercellular immunomodulatory molecule on human T cells by Segev et al. The discovery led to the development of therapeutics for autoimmune diseases including rheumatoid arthritis and psoriasis which are based on blocking this receptor.

CD66b:

CD66b is a costimulatory molecule that facilitates the immune system to respond to foreign substances. It is also used by the body's own immune system in response to harmful bacteria and viruses. The presence of CD66b on antigen presenting cells helps stimulate an adaptive immune response by cytotoxic T-lymphocytes leading to increased antibody production, cellular inflammation, and tissue damage.

The global CEA market was valued at USD 648 million in 2016.

Application Insights:

Ovarian cancer dominated the global CEA market in terms of revenue in 2017. This is due to the increasing prevalence of ovarian cancer, which has a high cure rate when diagnosed early with regular screening. According to estimates by the World Cancer Research Fund, an international organization dedicated to preventing cancer, around 5-10% of women develop invasive breast carcinoma and 2-6% develop invasive prostate carcinoma during their lifetime. Thus, increasing incidences of these cancers are expected to drive demand for carcinoembryonic antigen testing over the forecast period.

Breast cancer held a significant share in 2017 owing to factors such as increased awareness about risk factors associated with this disease coupled with rising incidence rates globally over recent years. In addition, several research studies have indicated that there is a strong association between hormone receptor positive breast tumor and CEA levels; thus providing potential growth avenues for this market segment during future years.

Regional Analysis:

North America dominated the global CEA market in 2017. This can be attributed to the presence of key players, increased research & development activities, and high adoption of technologically advanced products. Moreover, increasing cases of cancer are also expected to drive regional growth over the forecast period. For instance, as per statistics published by American Cancer Society in 2018, 1 in 2 women will be diagnosed with breast cancer and 1 in 6 men will be diagnosed with prostate cancer during their lifetime In addition to this, a rise is observed among individuals undergoing surgery for colorectal cancer due to better diagnosis facilities offered by healthcare providers coupled with growing awareness about early detection is further anticipated to boost revenue generation from North America region.

Growth Factors:

Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the CEA market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large pool of patients who will require CEA testing for diagnosis and treatment monitoring, driving the growth of the CEA market.
Rising demand for early detection tests: The early detection of cancers offers better prognosis and increased survival rates compared to late stage detection. There is an increasing demand for early detection tests, such as CEA testing, due to their ability to detect cancers at an earlier stage when they are more treatable. This is driving the growth of the CEA market.


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Carcinoembryonic Antigen (CEA) Market Research Report
By Type
CD66a, CD66b, CD66c, CD66d, CD66e, CD66f
By Application
Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, Thyroid Cancer, Others
By Companies
Roche Diagnostics, Abbott Diagnostics, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.

Global Carcinoembryonic Antigen (CEA) Market Report Segments:
The global Carcinoembryonic Antigen (CEA) market is segmented on the basis of:
Types
CD66a, CD66b, CD66c, CD66d, CD66e, CD66f
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, Thyroid Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics



Get Free Sample Report

Highlights of The Carcinoembryonic Antigen (CEA) Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
By Application:
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Carcinoembryonic Antigen (CEA) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?